Drug: Opsynvi (macitentan/tadalafil)

Manufacturer: Johnson & Johnson

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients of WHO functional class (FC) II-III

Disease: pulmonary arterial hypertension

Therapeutic Area: Pulmonary

Enrollment Form Link: referral form

Phone Number: 866-228-3546

Fax Number: 866-279-0669

Product Website: opsynvi.com